Bitcoin falls 4% to $99,237-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bitcoin falls 4% to $99,237

Jun 22, 2025 8:22 AM

(Reuters) -Bitcoin, the world's largest cryptocurrency by market value, was down by 4.13% at $99,237 at 10:52 a.m. ET (1452 GMT) on Sunday.

Ether, the second-largest cryptocurrency, was down by around 8.52% at $2,199.

Previous page： What's Going On With Palantir Technologies Shares Today? Next page： Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Palantir Technologies Shares Today?

Jun 28, 2024

Palantir Technologies Inc. ( PLTR ) shares are trading marginally higher on Friday. Peter Thiel, Chairman of Palantir Technologies ( PLTR ), shared his outlook on the future in an NBC News interview. He focused on AI, digital currencies, and his views on America’s current state. In an interview with BNN Bloomberg, Dan Ives, an analyst at Wedbush Securities, dismissed the notion...

Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug

Jun 28, 2024

10:35 AM EDT, 06/28/2024 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said Friday it had received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending an expanded marketing authorization for Imcivree to include children between 2 and 6 years old with neuroendocrine diseases. The company said it expects a decision from the...

Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment

Jun 28, 2024

10:34 AM EDT, 06/28/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Friday that it has submitted a new drug application for chenodiol for treating patients with cerebrotendinous xanthomatosis, or CTX, in the US. CTX is a rare progressive disorder of cholesterol metabolism that can affect the brain, spinal cord, tendons, eyes, and arteries, the company said. The submission...

Kirby Insider Sold Shares Worth $360,930, According to a Recent SEC Filing

Jun 28, 2024

10:36 AM EDT, 06/28/2024 (MT Newswires) -- David W Grzebinski, Director, CEO, on June 26, 2024, sold 3,000 shares in Kirby (KEX) for $360,930. Following the Form 4 filing with the SEC, Grzebinski has control over a total of 63,399 shares of the company, with 63,399 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/56047/000095017024078824/xslF345X03/ownership.xml Price: 121.15, Change: +1.10, Percent Change: +0.92 ...